Orphan CNS therapy developer Minoryx Therapeutics closed a $54.8m series C and MIT's The Engine co-led a $10.5m seed round for Foundation Alloy.
Minoryx Therapeutics, a Spain-based developer of treatments for orphan central nervous system disorders, completed a €51m ($54.8m) series C round yesterday that included an undisclosed amount of debt. The round was co-led by Columbus Venture Partners and Caixa Capital Risc, while CDTI, Fund+, Ysios Capital and other unnamed backers also took part. Minoryx was co-founded…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Talking Tech Transfer interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
